1 Min Read
Oct 31 (Reuters) - Citius Pharmaceuticals Inc
* Citius Pharmaceuticals, Inc. Receives “fast track” designation by FDA for mino-lok™ investigational trial Source text for Eikon: Further company coverage: (Bangalore.email@example.com)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.